SCHEMBL102939

SCHEMBL102939

N[C@H]1CC[C@@H](O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL62727 1.00
SCHEMBL56680 1.00
SCHEMBL10609809 0.96
Hydrochloric Acid SCHEMBL549259 0.96
Hydrochloric Acid SCHEMBL242771 0.96
Hydrochloric Acid SCHEMBL242772 0.96
SCHEMBL1671295 0.96
Methyl Alcohol SCHEMBL29002971 0.93 TSHR (0.39)
Hydrochloric Acid SCHEMBL1334662 0.93
SCHEMBL8891374 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 502 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116515782-A Amine dehydrogenase mutant and application thereof in chiral amine alcohol compound synthesis 中国科学院天津工业生物技术研究所 2023-08-01 CN claimed
CN-115925735-A Two-dimensional perovskite crystal and preparation method and application thereof 东南大学 2023-04-07 CN claimed
CN-111732518-A Preparation method of cis-4- [ (2-amino-3, 5-dibromobenzyl) amino ] cyclohexanol 河北宇辰医药科技有限公司 2020-10-02 CN claimed
US-9884814-B2 Acylguanidines for treating osteoarthritis MERCK PATENT GMBH (DE) 2018-02-06 US claimed
EP-2763990-B1 PYRROLOPYRAZINE KINASE INHIBITORS HOFFMANN LA ROCHE (CH) 2017-02-22 EP claimed
US-20150361037-A1 ACYLGUANIDINES FOR TREATING OSTEOARTHRITIS MERCK PATENT GMBH (DE) 2015-12-17 US claimed
US-8658646-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LAROCHE INC. (US) 2014-02-25 US claimed
US-7615568-B2 3-[2-(cis-4-aminocyclohexyloxy)-4-methylsulfonylbenzoyl-amino]-N-(5-chloropyridin-2-yl)pyridine-2-carboxamide,; anticoagulant; platelet glycoprotein receptor antagonist; thrombosis; orally; acylation of amino-pyridine by (methylthio)benzoic acid followed by oxidation, alkylation, carbonylation ELI LILLY AND COMPANY (US) 2009-11-10 US claimed
US-20080108594-A1 Antithrombotic Ethers ELI LILLY AND COMPANY (US) 2008-05-08 US claimed
EP-1644334-B1 ANTITHROMBOTIC ETHERS LILLY CO ELI (US) 2008-01-02 EP claimed
EP-1644334-A1 ANTITHROMBOTIC ETHERS Eli Lilly and Company (US) 2006-04-12 EP claimed
WO-2004108677-A1 ANTITHROMBOTIC ETHERS ELI LILLY AND COMPANY (US) 2004-12-16 WO claimed
EP-0909753-B1 Process for the preparation of trans-4-aminocyclohexanol LEHMANN BERND DR (DE) 2004-01-14 EP claimed
EP-0909753-A2 Process for the preparation of trans-4-aminocyclohexanol Great Lakes Chemical Konstanz GmbH (DE) 1999-04-21 EP claimed
US-12630529-B2 GCN2 modulator compounds Alesta Therapeutics BV (NL) 2026-05-19 US disclosed
US-12617799-B2 Pyrazolopyrimidinone compounds Orphagen Pharmaceuticals, Inc. (US) 2026-05-05 US disclosed
US-20260116869-A1 AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS NOVARTIS AG (CH) 2026-04-30 US disclosed
US-4170651-A ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1979-10-09 US disclosed
US-4115555-A ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1978-09-19 US disclosed
US-4051246-A ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1977-09-27 US disclosed